These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11829514)

  • 1. Biopiracy: distrust widens the rich-poor divide.
    Verma IM
    Mol Ther; 2002 Feb; 5(2):95. PubMed ID: 11829514
    [No Abstract]   [Full Text] [Related]  

  • 2. Break with tradition.
    Jayaraman KS
    Nature; 2006 Jul; 442(7101):342-3. PubMed ID: 16871181
    [No Abstract]   [Full Text] [Related]  

  • 3. $3m deal launches major hunt for drug leads in Brazil.
    Bonalume Neto R; Dickson D
    Nature; 1999 Jul; 400(6742):302. PubMed ID: 10432100
    [No Abstract]   [Full Text] [Related]  

  • 4. Herbal drug patenting in India: IP potential.
    Sahoo N; Manchikanti P; Dey SH
    J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug industry in India is threatened by free trade agreement].
    Jeppsson A
    Lakartidningen; 2009 Oct 7-13; 106(41):2589. PubMed ID: 19927922
    [No Abstract]   [Full Text] [Related]  

  • 6. More drugs, less protection.
    Nature; 2002 Sep; 419(6904):233. PubMed ID: 12239521
    [No Abstract]   [Full Text] [Related]  

  • 7. Patents of drugs extracted from Brazilian medicinal plants.
    Balbani AP; Silva DH; Montovani JC
    Expert Opin Ther Pat; 2009 Apr; 19(4):461-73. PubMed ID: 19441926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics at the crossroads.
    Nathan C
    Nature; 2004 Oct; 431(7011):899-902. PubMed ID: 15496893
    [No Abstract]   [Full Text] [Related]  

  • 9. Biopiracy of natural products and good bioprospecting practice.
    Efferth T; Banerjee M; Paul NW; Abdelfatah S; Arend J; Elhassan G; Hamdoun S; Hamm R; Hong C; Kadioglu O; Naß J; Ochwangi D; Ooko E; Ozenver N; Saeed ME; Schneider M; Seo EJ; Wu CF; Yan G; Zeino M; Zhao Q; Abu-Darwish MS; Andersch K; Alexie G; Bessarab D; Bhakta-Guha D; Bolzani V; Dapat E; Donenko FV; Efferth M; Greten HJ; Gunatilaka L; Hussein AA; Karadeniz A; Khalid HE; Kuete V; Lee IS; Liu L; Midiwo J; Mora R; Nakagawa H; Ngassapa O; Noysang C; Omosa LK; Roland FH; Shahat AA; Saab A; Saeed EM; Shan L; Titinchi SJ
    Phytomedicine; 2016 Feb; 23(2):166-73. PubMed ID: 26926178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. India pushes ahead with plant database.
    Jarayaman KS
    Nature; 2000 May; 405(6784):267. PubMed ID: 10830935
    [No Abstract]   [Full Text] [Related]  

  • 11. Biopiracy in India: Seed diversity and the scramble for knowledge.
    Banerjee M
    Phytomedicine; 2019 Feb; 53():296-301. PubMed ID: 30448389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM
    N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
    [No Abstract]   [Full Text] [Related]  

  • 13. Essential AIDS medications in India.
    Thomas J
    Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
    [No Abstract]   [Full Text] [Related]  

  • 14. Access to medicines in developing countries: ethical demands and moral economy.
    Cassier M; Correa M
    Dev World Bioeth; 2014 Aug; 14(2):ii-viii. PubMed ID: 25039326
    [No Abstract]   [Full Text] [Related]  

  • 15. Refining green gold.
    Labrador D
    Sci Am; 2003 Dec; 289(6):38-9. PubMed ID: 14631728
    [No Abstract]   [Full Text] [Related]  

  • 16. Out-licensing: a practical approach for improvement of access to medicines in poor countries.
    Friedman MA; den Besten H; Attaran A
    Lancet; 2003 Jan; 361(9354):341-4. PubMed ID: 12559883
    [No Abstract]   [Full Text] [Related]  

  • 17. [Opportunities in the pharmaceutical industry and the local development logic based on the Brazilian biomes: the basis for a national policy discussion].
    Villas Bôas Gde K; Gadelha CA
    Cad Saude Publica; 2007 Jun; 23(6):1463-71. PubMed ID: 17546337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From exotic spice to modern drug?
    Singh S
    Cell; 2007 Sep; 130(5):765-8. PubMed ID: 17803897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
    Spectar JM
    Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
    [No Abstract]   [Full Text] [Related]  

  • 20. Patent threat in emerging economies shifts to biotech.
    Jayaranam K
    Nat Biotechnol; 2008 May; 26(5):481-3. PubMed ID: 18464760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.